Abstract:The study aimed to confirm the association between some single nucleotide polymorphisms (SNPs) and metabolic dysfunction‐associated fatty liver disease (MAFLD) in western China. We found no association between these SNPs and the risk of MAFLD after Benjamini‐Hochberg adjustment. PNPLA3 rs738409 was associated with the AST levels in MAFLD patients. GCKR variants were associated with increased triglycerides levels and reduced serum fasting glucose in patients with MAFLD. In addition, there was no synergistic SNP–SNP interaction between PNPLA3 rs738409 and other SNPs on MAFLD. Introduction We aimed to confirm the association between some single nucleotide polymorphisms (SNPs) and metabolic dysfunction‐associated fatty liver disease (MAFLD) in western China. Methods A total of 286 cases and 250 healthy controls were enrolled in our study. All samples were genotyped for patatin‐like phospholipase domain containing 3 (PNPLA3) rs738409, transmembrane 6 superfamily member 2 (TM6SF2) rs58542926, membrane‐bound O‐acyltransferase domain containing 7 (MBOAT7) rs641738, glucokinase regulator (GCKR) rs1260326 and rs780094, and GATA zinc finger domain containing 2A (GATAD2A) rs4808199. Using logistic regression analysis, we evaluated the association between MAFLD and each SNP under different models. Multiple linear regression was used to find the association between SNPs and laboratory characteristics. Multifactor dimensionality reduction was applied to test SNP–SNP interactions. Results The recessive model and additive model of PNPLA3 rs738409 variant were related to MAFLD (odds ratio [OR] = 1.791 and 1.377, respectively, p = 0.038 and 0.027, respectively). However, after Benjamini‐Hochberg adjustment for multiple tests, all associations were no longer statistically significant. PNPLA3 rs738409 correlated with AST levels. GCKR rs780094 and rs1260326 negatively correlated with serum glucose but positively correlated with triglycerides in MAFLD. Based on MDR analysis, the best single‐locus and multilocus models for MAFLD risk were rs738409 and six‐locus models, respectively. Conclusions In the Han population in western China, no association was found between these SNPs and the risk of MAFLD. PNPLA3 rs738409 was associated with aspartate aminotransferase levels in MAFLD patients. GCKR variants were associated with increased triglyceride levels and reduced serum fasting glucose in patients with MAFLD.

Combining I148M and E167K Variants to Improve Risk Prediction for Nonalcoholic Fatty Liver Disease in Qingdao Han Population, China

Additive Effects of the Risk Alleles of Pnpla3 and Tm6sf2 on Non-Alcoholic Fatty Liver Disease (nafld) in A Chinese Population

Association of TCF7L2 rs7903146 Gene Polymorphism with the Risk of NAFLD and CAD in the Chinese Han Population

Sirtuin3 rs28365927 functional mutation confers to the high risk of non-alcoholic fatty liver disease in Chinese Han population

Association of patatin-like phospholipase domain-containing protein 3 gene polymorphisms with susceptibility of nonalcoholic fatty liver disease in a Han Chinese population.

NAFLD‐related gene polymorphisms and all‐cause and cause‐specific mortality in an Asian population: the Shanghai Changfeng Study

Association of Rs5764455 and Rs6006473 Polymorphisms in PARVB with Liver Damage of Nonalcoholic Fatty Liver Disease in Han Chinese Population

Genetic polymorphisms of Ca<SUP>2+</SUP> transport proteins and molecular chaperones in mitochondria-associated endoplasmic reticulum membrane and non-alcoholic fatty liver disease

Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population

Genetic Variation in PNPLA3 Confers Susceptibility to Nonalcoholic Fatty Liver Disease

Gwas-Identified Common Variants with Nonalcoholic Fatty Liver Disease in Chinese Children

I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders

The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population

Genetic variants associated with metabolic dysfunction‐associated fatty liver disease in western China

Genetic Variant I148M in PNPLA3 is Associated with the Ultrasonography-Determined Steatosis Degree in a Chinese Population.

PNPLA3 I148M Variant Affects Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients

SAMM50-rs2073082, -rs738491 and -rs3761472 Interactions Enhancement of Susceptibility to Non-Alcoholic Fatty Liver Disease

Association Between PNPLA3 Rs738409 Polymorphism and Nonalcoholic Fatty Liver Disease (NAFLD) Susceptibility and Severity

Combined effect of PNPLA3 rs738409 and UGT1A1 rs10929303 gene polymorphisms on nonalcoholic fatty liver disease in children

Correlation of Adiponectin Gene Polymorphisms rs266729 and rs3774261 With Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study